These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
246 related items for PubMed ID: 16961423
1. Introduction: new developments in the treatment of attention-deficit/hyperactivity disorder. Biederman J. J Clin Psychiatry; 2006; 67 Suppl 8():4-6. PubMed ID: 16961423 [No Abstract] [Full Text] [Related]
2. Treatment of hyperactivity in children with pervasive developmental disorders. Scahill L, Pachler M. J Child Adolesc Psychiatr Nurs; 2007 Feb; 20(1):59-62. PubMed ID: 17284238 [No Abstract] [Full Text] [Related]
3. Clonidine for treatment of attention-deficit/hyperactivity disorder. Med Lett Drugs Ther; 1996 Dec 06; 38(989):109-10. PubMed ID: 8957471 [No Abstract] [Full Text] [Related]
5. The role of alpha2-adrenergic agonists in attention-deficit/hyperactivity disorder. Sallee FR. Postgrad Med; 2010 Sep 06; 122(5):78-87. PubMed ID: 20861591 [Abstract] [Full Text] [Related]
6. Mechanism of action of alpha 2A-adrenergic agonists in attention-deficit/hyperactivity disorder with or without oppositional symptoms. Stahl SM. J Clin Psychiatry; 2010 Mar 06; 71(3):223-4. PubMed ID: 20331927 [No Abstract] [Full Text] [Related]
7. Treatment of attention-deficit-hyperactivity disorder. Elia J, Ambrosini PJ, Rapoport JL. N Engl J Med; 1999 Mar 11; 340(10):780-8. PubMed ID: 10072414 [No Abstract] [Full Text] [Related]
9. Transdermal methylphenidate (Daytrana) for ADHD. Med Lett Drugs Ther; 2006 Jun 19; 48(1237):49-51. PubMed ID: 16785850 [No Abstract] [Full Text] [Related]
10. [Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment]. Oberpichler-Schwenk H. Med Monatsschr Pharm; 2006 Nov 19; 29(11):415-6. PubMed ID: 17131689 [No Abstract] [Full Text] [Related]
11. [Methylphenidate (Ritalin) treatment in attention deficit hyperactivity disorder]. Shalev R, Gross-Tsur V. Harefuah; 1997 May 01; 132(9):672-5. PubMed ID: 9225587 [No Abstract] [Full Text] [Related]
12. Drugs under investigation for attention-deficit hyperactivity disorder. Schweitzer JB, Holcomb HH. Curr Opin Investig Drugs; 2002 Aug 01; 3(8):1207-11. PubMed ID: 12211416 [Abstract] [Full Text] [Related]
13. Mechanism of action of agents used in attention-deficit/hyperactivity disorder. Wilens TE. J Clin Psychiatry; 2006 Aug 01; 67 Suppl 8():32-8. PubMed ID: 16961428 [Abstract] [Full Text] [Related]
16. A new way to deliver psychiatric meds. Levin-Epstein M. Behav Healthc; 2006 Aug 01; 26(8):22-3. PubMed ID: 16961036 [No Abstract] [Full Text] [Related]
17. The neurology of attention deficit/hyperactivity disorder. Curatolo P. Brain Dev; 2005 Dec 01; 27(8):541-3. PubMed ID: 16310587 [No Abstract] [Full Text] [Related]
18. Methylphenidate an effective treatment for ADHD? McDougle CJ. J Autism Dev Disord; 2004 Oct 01; 34(5):593-4. PubMed ID: 15628613 [No Abstract] [Full Text] [Related]
19. Focalin XR for ADHD. Med Lett Drugs Ther; 2009 Mar 23; 51(1308):22-4. PubMed ID: 19305368 [No Abstract] [Full Text] [Related]